CEO Update – March 2019

CEO Update – March 2019 THE GREATEST BREAKTHROUGH IN 30 YEARS FOR THE TREATMENT OF TREATMENT RESISTANT DEPRESSION IS SPRAVATO / ESKETAMINE!   Is it really? Or are they just confirming what we have known for the last eight years?  Yes, finally Johnson and Johnson has successfully received FDA approval to provide the medical community…